| # | Drug | Count |
|---|---|---|
| 0 | IMATINIB | 31 |
| 1 | EVEROLIMUS | 10 |
| 2 | EVEROLIMUS TABLETS | 10 |
| 3 | AFATINIB | 6 |
| 4 | GEMCITABINE | 6 |
| 5 | GEMCITABINE HYDROCHLORIDE | 6 |
| 6 | IMATINIB MESYLATE | 6 |
| 7 | PEMETREXED | 6 |
| 8 | PEMETREXED DISODIUM | 6 |
| 9 | SIROLIMUS | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BROMOCRIPTINE MESYLATE | 1 | 0.0015 |
| 1 | DEXRAZOXANE FOR INJECTION | 1 | 0.0011 |
| 2 | AFATINIB | 6 | 0.0009 |
| 3 | EVEROLIMUS TABLETS | 10 | 0.0006 |
| 4 | ESTROGEN | 1 | 0.0003 |
| 5 | SIROLIMUS | 4 | 0.0003 |
| 6 | ERLOTINIB HYDROCHLORIDE | 3 | 0.0002 |
| 7 | IMATINIB MESYLATE | 6 | 0.0002 |
| 8 | CABERGOLINE | 1 | 0.0002 |
| 9 | EVEROLIMUS | 10 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 1 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 2 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 3 | Kinase Inhibitor [EPC] | 23 | 0.0000 |
| 4 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 5 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 6 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 8 | Parathyroid Hormone Analog [EPC] | 3 | 0.0000 |
| 9 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |